Pradeep Reddy
#393Chairman and Managing Director
70
Age
48y
Exp
41y
Tenure
8/10
Risk
🎓 not found · Madras School of Social Work
📜 not found
🏛️ None
CompensationTBP
Personality
7
Open
6
Cons
5
Extr
4
Agre
3
Neur
Granules India
Healthcare · Mid Cap
High Growth · Performance-Driven
About
Pradeep Reddy is the Chairman and Managing Director of Granules India, a Mid Cap company in the Healthcare sector with a market cap of ₹14K Cr. A Visionary leader with 48 years of experience, he is known for intuition-driven decision-making and organic builder strategy. Known for his focus on integrated manufacturing and willingness to bet on high-volume, niche generic APIs despite high competitive intensity.
FAQ
What is Pradeep Reddy's leadership style?
Pradeep Reddy is classified as a Visionary leader. He is intuition-driven in decision-making, with a category creator motivation and steady-marathon pace of execution.
What is Pradeep Reddy's educational background?
Pradeep Reddy holds a not found from Madras School of Social Work and a not found.
Who is the CEO of Granules India?
Pradeep Reddy is the Chairman and Managing Director of Granules India. He has been with the company for 41 years and in the current role for 30 years.
Leadership DNA
ArchetypeVisionary
MotivationCategory Creator
CrisisRestructurer
DecisionIntuition-Driven
GrowthOrganic Builder
PeopleNumbers Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployerDemanding Machine
BrandValue-Champion
FocusProduct Innovation
OrientationDeep Specialist
Leadership Evidence
“Known for his focus on integrated manufacturing and willingness to bet on high-volume, niche generic APIs despite high competitive intensity.”
⚡ Crisis●●●●○
He transitioned Granules India from a pure-play API manufacturer to a vertically integrated finished dosages player to insulate the company from commodity price volatility.
🎯 Motivation●●●●○
He pioneered the 'PFOS' (Pharmaceutical Formulation Intermediates) concept, creating a unique market niche that simplified the supply chain for generic drug makers.
👥 People●●●○○
The company maintains a rigorous focus on operational efficiency and cost-per-unit metrics as the core driver of their high-volume manufacturing model.
📈 Growth●●●●○
The company's expansion has been primarily driven by massive capital investment in internal manufacturing capacities like the Gagillapur facility rather than large-scale M&A.
💡 Innovation●●●●○
Granules excels at vertical integration and process chemistry to scale high-volume generic APIs and finished dosages efficiently rather than pioneering new molecular entities.
🏃 Pace●●●●○
The company operates on a consistent, capacity-driven expansion model focused on long-term supply contracts and steady margin improvement rather than rapid, speculative launches.
🌱 Purpose●●●○○
The company emphasizes 'affordable healthcare' as a core mission and maintains active CSR initiatives focused on community health and education in its manufacturing regions.
🏷️ Brand●●●●○
Its market reputation is built on the 'Granules' philosophy of delivering high-quality pharmaceutical products at the lowest possible cost through massive scale.
🤝 Customer●●●●●
Granules primarily operates as a B2B supplier of APIs and pharmaceutical formulations to global generic pharmaceutical companies and large retail chains.
💼 Employer●●●○○
As a high-growth, performance-driven manufacturing entity, it maintains a culture focused on operational efficiency, lean processes, and meeting aggressive production targets.
📋 Mandate
As it scales its complex API and finished dosage production, the firm requires a leader focused on margin optimization and global regulatory compliance.
🏢 Culture●●●●○
Known for highly aggressive operational efficiencies and growth-focused manufacturing targets.
Financials
Revenue FY25₹4K Cr
PAT FY25₹502 Cr
Rev CAGR 5Y6.1%
OPM16.4%
NPM11.3%
ROE13.5%
ROCE17.2%
P/E25
Fwd P/E18.6
P/B3.4
D/E45.4
Promoter39.3%
Institutional22.4%
Mkt Cap₹14K Cr
Compensation
To Be Published
Data being verified from audited reports
